I'm amazed only roughly 1/4 of shares issued were actually voted. I would have thought the numbers would be higher. Still, as some predicted, all proposals were approved. I'm still in the belief that the RS will only be done at the right time, and not solely to uplist at any cost. So far Gerald has demonstrated his resolve not to repeat the same mistake with the RS of Amarantus.
I especially like the option with the new share structure to bring 100% of 3CL Pharma/Sciences back under Todos ownership. And I love the transparency of Todos with the shareholders. Press releases for each new development, lots of Twitter posts responding to investor questions, and timely SEC filings. It's so refreshing to see an OTC company keep their shareholders informed, unlike so many others (IBIO, MONI, etc.), who have to guess and speculate on message boards to try to figure out what's going on. Very little speculation and guesswork with Todos. Gerald deserves a lot of credit for keeping us informed. I know some will appreciate the pic below to add to the many they have posted here.
News 
Market Data 
Discover 
